Skip to main content
Shervin Assassi, MD, Rheumatology, Houston, TX

Shervin Assassi MD


Professor & Director, Division of Rheumatology, University of Texas Health Science Center at Houston

Join to View Full Profile
  • 6431 Fannin StMsb 5.270Houston, TX 77030

  • Phone+1 713-500-6900

  • Fax+1 713-500-0580

Dr. Assassi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Rheumatology, 2003 - 2005
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2000 - 2003
  • Albert Ludwigs University Faculty of Medicine
    Albert Ludwigs University Faculty of MedicineClass of 1999

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2005 - 2025
  • Rheumatology
    American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma Cohorts  
    Daniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology

Press Mentions

  • Durable Efficacy for Drug Preventing Lung Progression in Systemic Sclerosis
    Durable Efficacy for Drug Preventing Lung Progression in Systemic SclerosisJuly 20th, 2022
  • Higher Cardiovascular Risks in Kawasaki Disease Persist 10-plus Years
    Higher Cardiovascular Risks in Kawasaki Disease Persist 10-plus YearsNovember 8th, 2020
  • Dr. Shervin Assassi: New Chair of the ACR Committee on Journal Publications
    Dr. Shervin Assassi: New Chair of the ACR Committee on Journal PublicationsApril 18th, 2019
  • Join now to see all

Grant Support

  • Interferon Regulatory Factor 7 Links Interferon Pathway Activation to the Exaggerates Fibrotic Response in Systemic SclerosisUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2023–2028
  • Combined Optical Coherence Elastography and Tomography for Assessing Skin Involvement in Systemic SclerosisUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2020–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: